Sequenom, Inc. (Sequenom) is a molecular diagnostic testing and genetics analysis company. The Company provides genomic and genetic analysis solutions for the molecular diagnostic and clinical research markets. Sequenom is engaged in researching, developing, and pursuing the commercialization of various noninvasive molecular diagnostic tests for prenatal genetic disorders, and diseases, women’s health-related disorders and diseases, ophthalmology, and other medical conditions such as oncology, infectious diseases, and autoimmunity. The Company conducts its business through two operating segments, Sequenom Laboratories and Sequenom Bioscience. The laboratories offer MaterniT21 PLUS test, the HerediT CF test, and the SensiGene RHD test. Sequenom bioscience manufactures and sells MassARRAY System, which provides quantitative DNA methylation analysis and comparative sequence analysis of haploid organisms, SNP discovery, and oligonucleotide quality control.